Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
Charles van Es, Chief Sales Officer of Vita Coco Company, Inc. (COCO), reported multiple transactions on 09/17/2025 under a Rule 10b5-1 plan. He purchased 20,000 shares via option exercises at a stated exercise price of $10.178 per share (reported as two non-qualified option exercises of 10,000 shares each) and sold 20,000 shares in Rule 10b5-1 plan transactions at a weighted average price of $42.04 per share (sales occurred across prices ranging from $42.00 to $42.19 and $42.00 to $42.18 as disclosed). Following the reported non-derivative transactions, his direct beneficial ownership figures listed are 94,328 shares and 84,328 shares on the lines reported.
Table II shows multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including currently exercisable options and several tranches that vest over future years, totaling significant option-based potential ownership.
Kenneth Sadowsky, a director of Vita Coco Company, Inc., sold 3,900 shares of common stock on 09/17/2025 under a Rule 10b5-1 trading plan at a weighted average price of $40.034 (individual trade prices ranged from $39.65 to $40.22). After the sale he beneficially owned 623,866 shares. The filing also discloses a fully vested, currently exercisable non-qualified stock option covering 27,300 underlying shares with a $10.178 exercise price. The Form 4 was filed by an attorney-in-fact on behalf of the reporting person and identifies the sale as pre-arranged under Rule 10b5-1.
Jane Prior, Chief Marketing Officer of Vita Coco Company, Inc. (COCO), reported insider activity showing simultaneous option exercise and open-market sales on 09/17/2025. She acquired 10,000 shares at $10.178 per share (Code M) and sold 10,000 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.043, with sale prices ranging from $42.00 to $42.19. After these transactions she beneficially owned 123,666 shares. The filing lists multiple outstanding non-qualified stock options at various exercise prices and vesting schedules, including 33,750 currently exercisable shares and several tranches vesting through 2035.
Insider sale under a Rule 10b5-1 plan: Liran Ira, a director of Vita Coco Company, Inc. (COCO), reported selling 50,000 shares of the issuer's common stock on 09/17/2025 at a weighted average price of $42.003 per share. The filing states the sales were effected pursuant to a Rule 10b5-1 trading plan. After the reported transactions, the form discloses 598,341 shares held directly and 692,579 shares held indirectly through the Ira Liran 2012 Family Trust. The Form 4 was signed by an attorney-in-fact on behalf of the reporting person on 09/19/2025.
Michael Kirban, Executive Chairman of Vita Coco Company, Inc. (COCO), reported an open-market sale of 30,000 shares of common stock executed under a Rule 10b5-1 trading plan at a weighted average price of $41.719 per share. The Form 4 shows the reporting person retains significant holdings: 1,549,049 shares indirectly held by the Michael Kirban 2010 Trust, 615,681 shares indirectly held by the Michael Kirban Revocable Trust, and 127,629 shares directly held. Multiple stock options across various strike prices and vesting schedules are also disclosed, including fully exercisable options and several tranches that vest over coming years.
Jonathan Burth, Chief Operating Officer of Vita Coco Company, Inc. (COCO), reported related transactions on 09/17/2025. He acquired 16,827 shares by exercising non-qualified stock options at an exercise price of $10.178 per share and sold 16,827 shares pursuant to a Rule 10b5-1 trading plan at a weighted average price of $42.546 per share (sales ranged from $42.50 to $42.73). Following these transactions his beneficial ownership of common stock decreased from 92,954 shares to 76,127 shares. The filing also lists multiple outstanding non-qualified stock options exercisable and unexercisable, with strike prices ranging from $10.178 to $33.36 and various vesting schedules.
Verlinvest Beverages SA, reporting as an officer of Vita Coco Company, Inc. (COCO), sold 3,000,000 shares of the issuer's common stock on 09/17/2025 at a price of $40.77 per share. The filing lists 4,097,161 shares beneficially owned following the transaction, held directly. The sale is described as a block sale executed under Rule 144 to an unaffiliated financial institution. The Form 4 is signed by Axelle Henry on 09/19/2025 and indicates the reporting person is a former 10% owner and an officer.
Martin Roper, a director and the CEO of Vita Coco Company, Inc. (COCO), reported multiple sales of common stock on September 16–17, 2025 effected under a Rule 10b5-1 trading plan. The Form 4 shows both direct and indirect dispositions: direct sales by the reporting person and sales of shares held in related family trusts. Prices reported are weighted averages around $40.00–$40.54 per share. The filing also discloses substantial stock option holdings that are largely vested and exercisable at strike prices ranging from $10.178 to $32.78, with multiple option grants representing significant potential common shares.
Corey Baker, listed as Chief Financial Officer of Vita Coco Company, Inc. (COCO), reported a series of transactions on 09/16/2025–09/18/2025. The filings show three separate acquisitions of 1,000 shares each at $16.91 and three corresponding sales of 1,000 shares each at $40. After those transactions the reporting person held 38,754 shares of common stock.
The Form 4 also discloses exercises or holdings of multiple non-qualified stock options with strike prices ranging from $16.91 to $33.36 covering in aggregate thousands of underlying shares (for example, 13,481 shares at $24.35 and 13,218 shares at $33.36). The sales of common stock were effected pursuant to a Rule 10b5-1 trading plan, as stated in the filing.
Form 144 notice filed for Vita Coco Company, Inc. (COCO). The filer intends to sell 3,000,000 shares of common stock through Morgan Stanley & Co. LLC on or about 09/17/2025, with an aggregate market value of $126,900,000. The shares were acquired on 12/21/2016 via a pre-IPO investment originally held by Verlinvest SA and later transferred to Verlinvest Beverages SA; payment was in cash. The issuer has 56,822,981 shares outstanding per the filing. The notice states there were no securities sold by the reporting person in the past three months and includes the required representation that the selling person is not aware of undisclosed material adverse information.